The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The Anti-Inflammatory Effects of Prostaglandins
Abstract
Long regarded as proinflammatory molecules, prostaglandins (PGs) also have anti-inflammatory effects. Both prostaglandin D 2 (PGD 2) and its dehydration end product 15-deoxy-Δ 12,14-prostaglandin J 2 (15d-PGJ 2) seem to play important roles in regulating inflammation, via both receptor-dependent (DP 1 and DP 2 receptors) and receptor-independent mechanisms. Intracellular effects of PGD 2 and 15d-PGJ 2 that may suppress inflammation include inhibition of nuclear factor-κB (NF-κB) by multiple mechanisms (IκB kinase inhibition and blockade of NF-κB nuclear binding) and activation of peroxisome proliferator-activated receptor-γ (PPAR-γ). Prostaglandin F 2α (PGF 2α) may also have important anti-inflammatory effects, although current data are limited. In animal models, expression of both PGD and PGF synthases declines during acute inflammation, only to rise again during the resolution phase, suggesting their possible role in resolving inflammation. Prostaglandin E 2 (PGE 2), the classic model of a proinflammatory lipid mediator, also has anti-inflammatory effects that are both potent and context dependent. Thus, accumulating data suggest that PGs not only participate in initiation, but may also actively contribute to the resolution of inflammation. Indeed, classic inhibitors of PG synthesis such as nonselective and cyclooxygenase-2 (COX-2) selective inhibitors (nonsteroidal anti-inflammatory drugs) may actually prolong inflammation when administered during the resolution phase. These effects may regulate not only tissue inflammation but also vascular disease, possibly shedding light on the controversy surrounding nonsteroidal anti-inflammatory drug use and its relation to myocardial infarction. In this review, we summarize the current understanding of PGs as dichotomous molecules in the inflammatory process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cipollone, F., Fazia, M. L., Iezzi, A., Ciabattoni, G., Pini, B., Cuccurullo, C., Ucchino, S., Spigonardo, F., Luca, M. D., Prontera, C., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000133192.39901.be · Cited by 109
RetractedInhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh-ishi, S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003505200 · Cited by 964
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708
Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.002 · Cited by 454
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Mor, A., Abramson, S. B., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.009 · Cited by 399
Self-citation15-Deoxy-Δ12,14-prostaglandin J2
Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110314200 · Cited by 392
15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
Kawahito, Y., Kondo, M., Tsubouchi, Y., Hashiramoto, A., Bishop-Bailey, D., Inoue, K.-I., Kohno, M., Yamada, R., Hla, T., & Sano, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9652 · Cited by 377
15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway
Straus, D. S. (2000) · Medical Entomology and Zoology · Cited by 371
Aronoff, D. M., Canetti, C., & Peters-Golden, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.559 · Cited by 360
15d-PGJ2: The anti-inflammatory prostaglandin?
Scher, J. U., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.09.008 · Cited by 348
Self-citationMurakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., & Kudo, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305108200 · Cited by 344
The role of NF-κB in the regulation of cell stress responses
Wang, T., Zhang, X., & Li, J. J. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00058-9 · Cited by 343
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Urade, Y., & Hayaishi, O. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00161-8 · Cited by 332
Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.
Fitzpatrick, F. A., & Wynalda, M. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44287-6 · Cited by 328
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Castrillo, A., Díaz-Guerra, M. J. M., Hortelano, S., Martín-Sanz, P., & Boscá, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1692-1698.2000 · Cited by 264
Effect of Prostaglandin E1 on Adjuvant Arthritis
ZURIER, R. B., & QUAGLIATA, F. (1971) · Nature · doi:10.1038/234304a0 · Cited by 258
Rajakariar, R., Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., Fitzgerald, D., Yaqoob, M. M., & Gilroy, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707394104 · Cited by 253
Articular cartilage repair by gene therapy using growth factor–producing mesenchymal cells
Gelse, K., von der Mark, K., Aigner, T., Park, J., & Schneider, H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10759 · Cited by 246
Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
Chiang, N., Arita, M., & Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.003 · Cited by 239
Prostaglandin synthases: recent developments and a novel hypothesis
Helliwell, R. J. A., Adams, L. F., & Mitchell, M. D. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.002 · Cited by 203
Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2
Ueno, N., Murakami, M., Tanioka, T., Fujimori, K., Tanabe, T., Urade, Y., & Kudo, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100429200 · Cited by 195
Pillinger, M. H., Capodici, C., Rosenthal, P., Kheterpal, N., Hanft, S., Philips, M. R., & Weissmann, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14540 · Cited by 181
Self-citationClaveau, D., Sirinyan, M., Guay, J., Gordon, R., Chan, C.-C., Bureau, Y., Riendeau, D., & Mancini, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4738 · Cited by 180
Prostaglandin E1 treatment of NZB/NZW mice
Zurier, R. B., Sayadoff, D. M., Torrey, S. B., & Rothfield, N. F. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200213 · Cited by 136
Gomez, P., Pillinger, M. H., Attur, M. G., Marjanović, N., Dave, M., Park, J., Bingham, C. O., Al-Mussawir, H., & Abramson, S. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6924 · Cited by 134
Self-citationNuclear receptor signaling in macrophages
Valledor, A. F., & Ricote, M. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.016 · Cited by 117
Pentreath, V. W., Rees, K., Owolabi, O. A., Philip, K. A., & Doua, F. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90085-s · Cited by 116
Kanaoka, Y., Fujimori, K., Kikuno, R. F., Sakaguchi, Y., Urade, Y., & Hayaishi, O. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01362.x · Cited by 113
Prostaglandin D2 in Sleep-Wake Regulation: Recent Progress and Perspectives
Hayaishi, O., & Urade, Y. (2002) · The Neuroscientist · doi:10.1177/107385840200800105 · Cited by 109
Thromboxanes: Synthase and Receptors
Shen, R., & Tai, H. (1998) · Journal of Biomedical Science · doi:10.1007/bf02253465 · Cited by 108
Hayaishi, O. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00766.2001 · Cited by 97
Shan, Z., Masuko, K., Dai, S., Nakamura, H., Kato, T., & Nishioka, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402424200 · Cited by 85
Wright, D. H., Metters, K. M., Abramovitz, M., & Ford‐Hutchinson, A. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701708 · Cited by 85
Akahoshi, T., Namai, R., Murakami, Y., Watanabe, M., Matsui, T., Nishimura, A., Kitasato, H., Kameya, T., & Kondo, H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10709 · Cited by 83
Activation of nuclear receptors by prostaglandins
Ide, T., Egan, K. M., Bell, L. C., & FitzGerald, G. A. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00418-3 · Cited by 63
Zingarelli, B., Hake, P. W., Mangeshkar, P., O’Connor, M., Burroughs, T. J., Piraino, G., Denenberg, A. G., & Wong, H. R. (2007) · Shock · doi:10.1097/shk.0b013e31804f56b9 · Cited by 61
A Cyclopentenone Prostaglandin Activates Mesangial MAP Kinase Independently of PPARγ
Wilmer, W. A., Dixon, C. L., Lu, L., Hilbelink, T., & Rovin, B. H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4301 · Cited by 60
15-Deoxy-Δ12,14-prostaglandin J2 Inhibits IL-10 and IL-12 Production by Macrophages
Azuma, Y., Shinohara, M., Wang, P., & Ohura, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4783 · Cited by 55
Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular Endothelium
Chen, N.-G., & Han, X. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4628 · Cited by 45
Chan, E. S. L., Zhang, H., Fernandez, P., Edelman, S. D., Pillinger, M. H., Ragolia, L., Palaia, T. A., Carsons, S. E., & Reiss, A. B. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2109 · Cited by 42
Self-citationPillinger, M. H., Dinsell, V., Apsel, B., Tolani, S., Marjanović, N., Chan, E. S. L., Gomez, P., Clancy, R. M., Chang, L., & Abramson, S. B. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705864 · Cited by 18
Self-citation
Cited by
Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M., De Medina, P., Monsarrat, B., Perret, B., Silvente-Poirot, S., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003657 · Cited by 633
Multifaceted roles of PGE2 in inflammation and cancer
Nakanishi, M., & Rosenberg, D. W. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0342-8 · Cited by 591
Metabolites released from apoptotic cells act as tissue messengers
Medina, C. B., Mehrotra, P., Arandjelovic, S., Perry, J. S. A., Guo, Y., Morioka, S., Barron, B., Walk, S. F., Ghesquière, B., Krupnick, A. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2121-3 · Cited by 506
Macrophages and the maintenance of homeostasis
Mosser, D. M., Hamidzadeh, K., & Goncalves, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00541-3 · Cited by 505
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 437
Metadata
- Authors
- Scher, J. U., & Pillinger, M. H.
- Venue
- Journal of Investigative Medicine
- Publisher
- SAGE Publications
- Published
- 2009-08
- Volume
- 57
- Issue
- 6
- Pages
- 703-708
- ISSN
- 1081-5589 (ISSN-L)
- 1708-8267
- OpenAlex
- W1953077261
- Cited by
- 259
- References
- 54
- FWCI
- 13.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.